Filing Flows › Davita (DVA) › Q2 2025
Davita (DVA) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 5, 2025
Davita (DVA) reported revenue of $3.4B for the second quarter 2025 (Q2 2025), +6% from a year earlier and +5% from the quarter before. Operating margin was 15.9%, net earnings $199M (5.9% of revenue).
Davita, Q2 2025: revenue $3.4B (+6% year over year), operating margin 15.9%, net earnings $199M, operating cash flow $324M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.4B | +5% | +6% |
| Operating profit | $538M | +23% | +6% |
| Net earnings | $199M | +22% | -10% |
| Operating cash flow | $324M | +80% | -59% |
| Free cash flow | $203M | +453% | -70% |
What changed
Revenue was $3.4B in Q2 2025, up 6% year over year and up 5% from the previous quarter. U. S. Dialysis and Related Lab Services was the largest line at 86% of revenue. Other - Ancillary Services added $0.12B year over year (up 35%), 64% of the total change.
Operating profit was $0.54B, a 15.9% margin (unchanged year over year). Of the extra revenue versus a year earlier, 16% reached operating profit, above the 16% margin then. Total costs grew 6% against revenue growth of 6%. The fastest-growing cost line was General & admin (+12%). Net earnings were $0.20B, down 10% year over year. The effective tax rate was 25.4%.
Operating cash flow was $0.32B (down 59% year over year), 118% of net income including minority interests. Non-cash charges added back $0.17B of depreciation and amortization and $0.03B of share-based compensation. Working capital and other items used $0.16B. Capital expenditures of $0.12B left free cash flow of $0.20B.
Questions
What was Davita's revenue in the second quarter 2025?
Davita (DVA) reported revenue of $3.4B for the second quarter 2025 (Q2 2025), +6% from a year earlier and +5% from the quarter before.
Was Davita profitable in the second quarter 2025?
Operating profit was $538M (15.9% of revenue) and net earnings $199M.
Source: Davita 10-Q on SEC EDGAR.